Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis
JHEP Reports(2021)
摘要
•Biochemical markers can help estimate risk of progression in patients with primary biliary cholangitis.•Data from the POISE trial were used to calculate GLOBE score and aminotransferase-to-platelet ratio index.•Obeticholic acid treatment was associated with a shift to lower risk of progression.
更多查看译文
关键词
APRI,Cholestasis,PBC,Risk stratification
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要